title: Thymidine kinase gene modified bone marrow mesenchymal stem cells as vehicles for antitumor therapy.
authors.affiliation: Stem Cells and Regeneration Program, School of Biomedical Sciences and Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, NT Hong Kong, People's Republic of China.
authors.forename: Chao
authors.initials: C
authors.lastname: Song
authors.forename: Juanjuan
authors.initials: J
authors.lastname: Xiang
authors.forename: Jingqun
authors.initials: J
authors.lastname: Tang
authors.forename: David G
authors.initials: DG
authors.lastname: Hirst
authors.forename: Junwei
authors.initials: J
authors.lastname: Zhou
authors.forename: Kai-Ming
authors.initials: KM
authors.lastname: Chan
authors.forename: Gang
authors.initials: G
authors.lastname: Li